当前位置:首页 - 行情中心 - 精华制药(002349) - 财务分析 - 资产负债表

精华制药

(002349)

  

流通市值:64.15亿  总市值:64.32亿
流通股本:8.12亿   总股本:8.14亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金842,827,007.11751,208,813.22922,469,572.89933,266,979.42
应收票据及应收账款288,259,063.8316,701,738.88299,692,344.9241,908,949.93
其中:应收票据41,734,728.1546,535,252.0639,301,314.3422,839,625.35
应收账款246,524,335.65270,166,486.82260,391,030.56219,069,324.58
应收款项融资99,149,321.0779,879,290.6106,305,828.5197,249,349.9
预付款项15,515,207.8617,091,897.3424,386,419.8520,389,534.3
其他应收款合计3,708,293.11,687,048.374,178,705.942,703,334.96
存货303,364,221.74320,565,518.02315,483,984.74307,653,469.48
一年内到期的非流动资产-2,438,333.321,270,499.99115,500
其他流动资产485,948.11,741,731.641,127,729.63802,570.84
流动资产平衡项目0000
流动资产合计1,861,912,528.531,793,751,316.591,800,443,905.631,729,043,080.01
非流动资产:
长期应收款44,000,00044,000,00044,000,00044,000,000
长期股权投资39,501,932.7339,637,069.3140,004,953.7640,116,827.21
其他权益工具投资4,950,0004,950,0004,950,0004,950,000
其他非流动金融资产---1,900,000
投资性房地产259,446,212.29261,723,329.33264,000,446.31266,277,563.32
固定资产605,233,517.07617,813,075.44628,842,933.12644,999,088.21
在建工程63,073,462.6863,728,495.8162,801,803.8461,511,622.34
使用权资产878,790.871,107,727.861,634,883.351,905,202.91
无形资产63,206,831.7263,793,145.5864,417,167.8565,064,381.94
商誉167,944,061.4167,944,061.4167,944,061.4167,944,061.4
递延所得税资产12,568,568.3111,977,191.0511,970,007.8512,348,670.42
其他非流动资产944,871944,871944,8711,617,071
非流动资产平衡项目0000
非流动资产合计1,261,748,248.071,277,618,966.781,291,511,128.481,312,634,488.75
资产平衡项目0000
资产总计3,123,660,776.63,071,370,283.373,091,955,034.113,041,677,568.76
流动负债:
短期借款21,021,949.7310,008,637.521,024,805.5421,026,016.66
应付票据及应付账款158,557,194.11171,276,373.46143,955,185.87139,605,589.45
其中:应付票据25,702,493.1525,817,381.4419,383,314.9716,578,921.54
应付账款132,854,700.96145,458,992.02124,571,870.9123,026,667.91
合同负债17,286,822.414,954,223.8824,416,332.8545,098,403.86
应付职工薪酬53,969,180.5745,990,148.8249,750,716.7260,419,240.2
应交税费20,045,066.0922,295,427.0330,454,194.733,510,247.25
其他应付款合计73,098,597.8674,522,502.372,228,963.4588,611,568.49
一年内到期的非流动负债436,130.61505,686.64680,308.46679,435.08
其他流动负债2,414,317.391,645,311.982,570,781.415,680,267.37
流动负债平衡项目0000
流动负债合计346,829,258.76341,198,311.61345,081,289394,630,768.36
非流动负债:
租赁负债369,329.43451,228.37504,790.9912,755.67
递延收益9,699,149.1710,188,221.1610,352,150.6110,532,224.28
递延所得税负债12,136,054.2512,230,388.3111,878,549.4811,736,384.58
其他非流动负债104,674.22109,552.22117,535.22121,918.22
非流动负债平衡项目0000
非流动负债合计22,309,207.0722,979,390.0622,853,026.2123,303,282.75
负债平衡项目0000
负债合计369,138,465.83364,177,701.67367,934,315.21417,934,051.11
所有者权益(或股东权益):
实收资本(或股本)814,180,908814,180,908814,180,908814,180,908
资本公积905,923,399.69905,923,399.69905,923,399.69905,923,399.69
专项储备4,863,698.184,112,612.93,683,879.52,887,068.4
盈余公积100,975,384.39100,975,384.39100,975,384.39100,975,384.39
未分配利润707,214,105.28666,472,182.12664,670,651.48576,999,323.18
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,533,157,495.542,491,664,487.12,489,434,223.062,400,966,083.66
少数股东权益221,364,815.23215,528,094.6234,586,495.84222,777,433.99
股东权益平衡项目0000
股东权益合计2,754,522,310.772,707,192,581.72,724,020,718.92,623,743,517.65
负债和股东权益合计3,123,660,776.63,071,370,283.373,091,955,034.113,041,677,568.76
公告日期2023-10-302023-08-262023-04-292023-03-30
审计意见(境内)标准无保留意见
TOP↑